Novo Nordisk beats quarterly profit forecasts, lifts outlook on Wegovy pill strength - Reuters

Chronological Source Flow
Back

AI Fusion Summary

Novo Nordisk reported first‑quarter earnings that surpassed analysts’ expectations, driven by strong sales of its obesity drug Wegovy. The company raised its 2024 guidance, citing continued demand and higher pricing for the weight‑loss therapy.
#NOVE_NORDISK #WEGO #Q1_EARNINGS #OBESITY_TREATMENT #REUTERS #US_MARKET
06/05 08:36 google.com
3 Πηγές

Novo Nordisk beats quarterly profit forecasts, lifts outlook on Wegovy pill strength - Reuters

POLITICS
06/05 08:42 investing.com

Novo Nordisk’s Q1 profit beats forecasts

06/05 10:22 ft.com

Novo Nordisk lifts forecasts after strong demand for Wegovy weight-loss pill

POLITICS
Comments
Loading...
0